Immune-mediated Liver Injury in Hepatitis B Virus Infection

키워드

참고문헌 (81)

1. Park, S. H., "Immune responses to HCV other hepatitis viruses", Immunity, 40, pp.13~24 (2014)
2. Chisari, F. V., "Pathogenesis of hepatitis B virus infection", Pathol. Biol, 58, pp.258~266 (2010)
3. Ocama, P., "Hepatitis B virus infection: current status", Am. J. Med, 118, pp.1413~ (2005)
4. Guidotti, L. G., "Immunobiology pathogenesis of viral hepatitis", Annu. Rev. Pathol, 1, pp.23~61 (2006)
5. Guidotti, L. G., "Viral clearance without destruction of infected cells during acute HBV infection", Science, 284, pp.825~829 (1999)
6. Thimme, R., "CD8(+) T cells mediate viral clearance disease pathogenesis during acute hepatitis B virus infection", J. Virol, 77, pp.68~76 (2003)
7. Rehermann, B., "Immunology of hepatitis B virus hepatitis C virus infection", Nat. Rev. Immunol, 5, pp.215~229 (2005)
8. Maini, M. K., "The role of virus-specific CD8(+) cells in liver damage viralcontrol during persistent hepatitis B virus infection", J. Exp. Med, 191, pp.1269~1280 (2000)
9. Sells, M. A., "Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA", Proc. Natl. Acad. Sci. U. S. A, 84, pp.1005~1009 (1987)
10. Quasdorff, M., "A concerted action of HNF4alpha HNF1alpha links hepatitis B virus replication to hepatocyte differentiation", Cell. Microbiol, 10, pp.1478~1490 (2008)
11. Schulze-Bergkamen, H., "Primary human hepatocytes--a valuable tool for investigation of apoptosis hepatitis B virus infection", J. Hepatol, 38, pp.736~744 (2003)
12. Guidotti, L. G., "High-level hepatitis B virus replication in transgenic mice", J. Virol, 69, pp.6158~6169 (1995)
13. McMahon, B. J., "The natural history of chronic hepatitis B virus infection", Hepatology, 49, pp.S45~S55 (2009)
14. Chisari, F. V., "Hepatitis B virus immunopathogenesis", Annu. Rev. Immunol, 13, pp.29~60 (1995)
15. Ferrari, C., "Immunopathogenesis of hepatitis B", J. Hepatol, 39(Suppl 1), pp.S36~S42 (2003)
16. Ganem, D., "Hepatitis B virus infection--natural history clinical consequences", N. Engl. J. Med, 350, pp.1118~1129 (2004)
17. Servet-Delprat, C., "Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus", J. Virol, 74, pp.4387~4393 (2000)
18. Su, F., "Role of NF-kappaB myc proteins in apoptosis induced by hepatitis B virus HBx protein", J. Virol, 75, pp.215~225 (2001)
19. Terradillos, O., "p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo in vitro", Oncogene, 17, pp.2115~2123 (1998)
20. Kim, K. H., "Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP enhancement of death-inducing signal", EMBO J, 22, pp.2104~2116 (2003)
21. Miao, J., "Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression", Cancer Lett, 236, pp.115~124 (2006)
22. Shirakata, Y., "Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential", J. Biol. Chem, 278, pp.22071~22078 (2003)
23. Brenner, C., "Decoding cell death signals in liver inflammation", J. Hepatol, 59, pp.583~594 (2013)
24. Kroemer, G., "Mitochondrial membrane permeabilization in cell death", Physiol. Rev, 87, pp.99~163 (2007)
25. Kirby, J., "Socio-environmental influences on physical activity among young people: a qualitative study", Health Educ. Res, 28, pp.954~969 (2013)
26. Krtolica, A., "Senescent fibroblasts promote epithelial cell growth tumorigenesis:a link between cancer aging", Proc. Natl. Acad. Sci. U. S. A, 98, pp.12072~12077 (2001)
27. Acs, G., "Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees", Proc. Natl. Acad. Sci. U. S. A, 84, pp.4641~4644 (1987)
28. Diao, J., "X protein of hepatitis B virus inhibits Fas-mediated apoptosis is associated with up-regulation of the SAPK", JNK pathway, 2001, pp.276, 8328~8340
29. Pan, J., "Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B", J. Gen. Virol, 82, pp.171~182 (2001)
30. Shih, W. L., "Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway", J. Biol. Chem, 275, pp.25858~25864 (2000)
31. Marusawa, H., "HBXIP functions as a cofactor of survivin in apoptosis suppression", EMBO J, 22, pp.2729~2740 (2003)
32. Lee, Y. I., "The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade", J. Biol. Chem, 276, pp.16969~16977 (2001)
33. Elmore, L. W., "Hepatitis B virus X protein p53 tumor suppressor interactions in the modulation of apoptosis", Proc. Natl. Acad. Sci. U. S. A, 94, pp.14707~14712 (1997)
34. Huo, T. I., "Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis", Oncogene, 20, pp.3620~3628 (2001)
35. Arzberger, S., "Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus", J. Virol, 84, pp.11994~12001 (2010)
36. Assrir, N., "Role of the hepatitis B virus proteins in pro- anti-apoptotic processes", Front. Biosci, 15, pp.12~24 (2010)
37. Su, F., "Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha", Proc. Natl. Acad. Sci. U. S. A, 94, pp.8744~8749 (1997)
38. Lindros, K. O., "Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver", Cell Biol. Toxicol, 13, pp.257~262 (1997)
39. Locaputo, S., "Zonal regulation of gene expression during liver regeneration of urokinase transgenic mice", Hepatology, 29, pp.1106~1113 (1999)
40. Sitia, G., "Antiplatelet therapy prevents hepatocellular carcinoma improves survival in a mouse model of chronic hepatitis B", Proc. Natl. Acad. Sci. U. S. A, 109, pp.E2165~E2172 (2012)
41. Iannacone, M., "Platelets mediate cytotoxic T lymphocyte-induced liver damage", Nat. Med, 11, pp.1167~1169 (2005)
42. Norris, S., "Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes", J. Hepatol, 28, pp.84~90 (1998)
43. Ramadori, G., "Inflammation, damage repair, immune cells, liver fibrosis: specific or nonspecific, this is the question", Gastroenterology, 127, pp.997~1000 (2004)
44. Bonorino, P., "Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B C", J. Hepatol, 51, pp.458~467 (2009)
45. Oliviero, B., "Natural killer cell functional dichotomy in chronic hepatitis B chronic hepatitis C virus infections", Gastroenterology, 137, pp.1151~1160 (2009)
46. Zhao, J., "Natural killer cells are characterized by the concomitantly increased interferongamma cytotoxicity in acute resolved hepatitis B patients", PLoS One, 7, pp.e49135~ (2012)
47. Varchetta, S., "Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection", Hepatology, 56, pp.841~849 (2012)
48. Nattermann, J., "Surface expression cytolytic function of natural killer cell receptors is altered in chronic hepatitis C", Gut, 55, pp.869~877 (2006)
49. Biron, C. A., "Natural killer cells in antiviral defense:function regulation by innate cytokines", Annu. Rev. Immunol, 17, pp.189~220 (1999)
50. Guidotti, L. G., "Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes", Immunity, 4, pp.25~36 (1996)
51. Dunn, C., "Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage", J. Exp. Med, 204, pp.667~680 (2007)
52. Zhang, Z., "Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients", Hepatology, 53, pp.73~85 (2011)
53. Arababadi, M. K., "Serum Levels of IL-10 IL-17A in Occult HBV-Infected South-East Iranian Patients", Hepat. Mon, 10, pp.31~35 (2010)
54. Arababadi, M. K., "Non-association of IL-12 +1188 IFN-gamma +874 polymorphisms with cytokines serum level in occult HBV infected patients", J. Gastroenterol, 17, pp.30~35 (2011)
55. Khorramdelazad, H., "High Serum Levels of TGF-beta in Iranians With Chronic HBV Infection. Hepat. Mon. 12 : e7581", Hepat. Mon, 12, pp.e7581~ (2012)
56. Wieland, S. F., "Stealth cunning: hepatitis B hepatitis C viruses", J. Virol, 79, pp.9369~9380 (2005)
57. Bigger, C. B., "DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection", J. Virol, 75, pp.7059~7066 (2001)
58. Su, A. I., "Genomic analysis of the host response to hepatitis C virus infection", Proc. Natl. Acad. Sci. U. S. A, 99, pp.15669~15674 (2002)
59. Seeger, C., "Hepatitis B virus biology", Microbiol. Mol. Biol. Rev, 64, pp.51~68 (2000)
60. Bertoletti, A., "HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen", Proc. Natl. Acad. Sci. U. S. A, 88, pp.10445~10449 (1991)
61. Missale, G., "HLA-A31- HLAAw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis", J. Exp. Med, 177, pp.751~762 (1993)
62. Rehermann, B., "The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during after acute viral hepatitis", J. Exp. Med, 181, pp.1047~1058 (1995)
63. Baumert, T. F., "Pathogenesis of hepatitis B virus infection", World J. Gastroenterol, 13, pp.82~90 (2007)
64. Wieland, S., "Genomic analysis of the host response to hepatitis B virus infection", Proc. Natl. Acad. Sci. U. S. A, 101, pp.6669~6674 (2004)
65. Ando, K., "Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo", J. Immunol, 152, pp.3245~3253 (1994)
66. Kondo, T., "Essential roles of the Fas ligin the development of hepatitis", Nat. Med, 3, pp.409~413 (1997)
67. Galle, P. R., "Involvement of the CD95 (APO-1", Fas) receptor ligin liver damage, 1995, pp.182, 1223~1230
68. Kakimi, K., "Blocking chemokine responsive to gamma-2", interferon (IFN)-gamma inducible protein monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes, 2001, pp.194, 1755~1766
69. Sitia, G., "Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes", Proc. Natl. Acad. Sci. U. S. A., 99, pp.13717~13722 (2002)
70. Sitia, G., "MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs", J. Clin. Invest, 113, pp.1158~1167 (2004)
71. Iannacone, M., "Antiplatelet drug therapy moderates immune-mediated liver disease inhibits viral clearance in mice infected with a replication-deficient adenovirus", Clin. Vaccine Immunol, 14, pp.1532~1535 (2007)
72. Lang, P. A., "Aggravation of viral hepatitis by platelet-derived serotonin", Nat. Med, 14, pp.756~761 (2008)
73. Tsui, L. V., "Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes", Proc. Natl. Acad. Sci. U. S. A, 92, pp.12398~12402 (1995)
74. Urbani, S., "Acute phase HBV-specific T cell responses associated with HBV persistence after HBV", HCV coinfection, 2005, pp.41, 826~831
75. Barnaba, V., "Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection", J. Immunol, 143, pp.2650~2655 (1989)
76. Burton, D. R., "Antibody virus : binding neutralization", Virology, 270, pp.1~3 (2000)
77. Schilling, R., "Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen virions", J. Virol, 77, pp.8882~8892 (2003)
78. Rehermann, B., "The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response", Nat. Med, 2, pp.1104~1108 (1996)
79. Moss, B., "Live recombinant vaccinia virus protects chimpanzees against hepatitis B", Nature, 311, pp.67~69 (1984)
80. Shouval, D., "Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation : a concise review", Hepatology, 32, pp.1189~1195 (2000)
81. Cooper, N. R., "Complement, viruses, virus-infected cells", Springer Semin. Immunopathol, 6, pp.327~347 (1983)

관련 논문AI추천